A Prospective, Open-label, Randomized Trial of Doxycycline Versus Azithromycin for the Treatment of Uncomplicated Murine Typhus
Author(s) -
Paul N. Newton,
Valy Keolouangkhot,
Sue J. Lee,
Khamla Choumlivong,
Siho Sisouphone,
Khamloune Choumlivong,
Manivanh Vongsouvath,
Mayfong Mayxay,
Vilada Chansamouth,
Viengmon Davong,
Koukeo Phommasone,
Joy Sirisouk,
Stuart D. Blacksell,
Pruksa Nawtaisong,
Catrin E. Moore,
Josée Castonguay-Vanier,
Sabine Dittrich,
Sayaphet Rattanavong,
Ko Chang,
Chirapha Darasavath,
Oudayvone Rattanavong,
Daniel H. Paris,
Rattanaphone Phetsouvanh
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy563
Subject(s) - azithromycin , medicine , doxycycline , regimen , murine typhus , randomized controlled trial , scrub typhus , rickettsia typhi , gastroenterology , antibiotics , surgery , typhus , virology , biology , microbiology and biotechnology
Murine typhus, or infection with Rickettsia typhi, is a global but neglected disease without randomized clinical trials to guide antibiotic therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom